21 results
8-K
XCUR
Exicure Inc
1 Dec 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
previously disclosed wind down of historical biotechnology activities and transition to an exploration of broader strategic alternatives, it was no longer … research and development expenses with its wind down activities in 2023. As a result, approximately $0.6 million of expenses were incorrectly
DEFA14A
XCUR
Exicure Inc
14 Nov 22
Additional proxy soliciting materials
4:20pm
and corporate progress.
Corporate Update
As previously reported, on September 26, 2022, the Company announced its commitment to a plan to wind down
8-K
EX-99.1
k45j3dcqlzi
14 Nov 22
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:15pm
8-K
s86rud41vg97ok3x9
27 Sep 22
Entry into a Material Definitive Agreement
7:13am
424B3
lv1h1gwkg z6j
20 Jul 22
Prospectus supplement
4:51pm
8-K
urc96gd
5 Jan 22
Termination of a Material Definitive Agreement
5:08pm
424B5
y12zdngrqwfz
16 Dec 21
Prospectus supplement for primary offering
8:13am
8-K
EX-99.1
moqckkp1 feaj1
10 Dec 21
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus
5:25pm
8-K
ek8a4gyz
10 Dec 21
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus
5:25pm
424B3
6lkc ma8d3e1mt2
10 May 19
Prospectus supplement
4:38pm
424B3
o63c0wj71 4ym
10 May 19
Prospectus supplement
4:35pm